Human genetic material was illegally exported
Print Edition
SIX companies and an institution, including Shanghai’s Huashan Hospital and the China branch of global biopharmaceutical giant AstraZeneca, which is registered in Shanghai, have been punished by China’s Ministry of Science and Technology for violations of human genetic resources management regulations.
The Huashan Hospital, affiliated to Fudan University, and biotech firm BGI in Shenzhen, were found to have conducted international cooperation and research on Chinese human genetic resources with the University of Oxford without permission.
The hospital was ordered to stop the research immediately and destroy all genetic resources materials and relevant research data which has not been passed overseas.
AstraZeneca (China) was given a warning. The human genetic resources materials illegally used was confiscated and destroyed.
Amoy Dx, a biological medicine company based in Xiamen, Q2 Solutions, a global clinical trials laboratory services organization based in Beijing, and BGI were also punished by the ministry.
The Suzhou outlet of pharmaceutical company AppTec Group was found to have exported 5,165 human genetic resources, or human serum, overseas as canine plasma illegally.
It was given a warning, had the human genetic resources materials in the project confiscated and destroyed, and its international cooperation and overseas activities regarding China’s human genetic resources was suspended.
It will not be able to resume this work until its rectification passes inspection.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 沪ICP证：沪ICP备05050403号-1
- |
- 互联网新闻信息服务许可证：31120180004
- |
- 网络视听许可证：0909346
- |
- 广播电视节目制作许可证：沪字第354号
- |
- 增值电信业务经营许可证：沪B2-20120012
Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
